Corgtex
Featured Knowledge
Recent Meetings
Innovation & AI Working Group Kickoff
Discussed AI governance, drug discovery ML platforms, and digital twin pilots....
Q4 2024 Earnings Final Review
Reviewed Q4 2024 performance showing $88.8B total revenue. Innovative Medicine ($57B) driven by DARZ...
Board of Directors Quarterly Review
Reviewed board governance, committee reports, and FY2025 financial outlook....
Executive Committee Strategic Planning
Aligned on 2025 strategy post-Kenvue. Confirmed focus on high-growth Innovative Medicine and MedTech...
ESG & Regulatory Compliance Update
Reviewed Health for Humanity progress. On track for internal climate targets but facing challenges w...
Your To-Dos
Active Tensions
Live Activity
Recently Published
Action
Complete Abiomed DACH Hiring Plan
By Joaquin Duato · 4d ago
Action
Submit FY2025 ESG Targets to RCSC
By Joaquin Duato · 4d ago
Action
File TREMFYA EU Label Extension
By Joaquin Duato · 4d ago
Action
Schedule Board Strategic Offsite for Q2
By Joaquin Duato · 4d ago
Proposal
Decentralized Talent Mobility Program
By Peter Fasolo · 4d ago
Tension
Clinical Staff Retention in Key R&D Sites
By Joaquin Duato · 5d ago
Tension
MedTech Regulatory Approval Delays in EU
By Joaquin Duato · 5d ago
Tension
Post-Kenvue Brand Identity Transition
By Joaquin Duato · 5d ago
Proposal
Mandate Tier-1 Supplier ESG Reporting
By Vanessa Broadhurst · 5d ago
Proposal
Cross-Segment AI Governance Policy
By Michael Ullmann · 5d ago